Figure 1
Workflow Diagram to evaluate the treatment effect of Apatinib Mesylate on advanced progressed lung adenocarcinoma patients with EGFR-TKI resistance.
Figure 1 | Scientific Reports
Workflow Diagram to evaluate the treatment effect of Apatinib Mesylate on advanced progressed lung adenocarcinoma patients with EGFR-TKI resistance.
